LMF Acquisition Opportunities (LMAO) to Combine with SeaStar Medical in $85M Deal

LMF (NASDAQ:LMAO) has entered into a definitive agreement to combine with clinical biotech firm SeaStar Medical at an enterprise value of $85 million. Denver-based SeaStar is developing a therapeutic method to address hyperinflammation with particular applications in treating COVID-19 patients. The combined company is expected to trade on the Nasdaq once the deal is completed
Read More